Published in Int Urogynecol J Pelvic Floor Dysfunct on January 01, 1999
Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial. Br J Clin Pharmacol (2005) 1.18
Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach. PLoS One (2011) 1.16
Approach to urinary incontinence in women. Diagnosis and management by family physicians. Can Fam Physician (2003) 1.08
M2 mediated contractions of human bladder from organ donors is associated with an increase in urothelial muscarinic receptors. Neurourol Urodyn (2007) 1.05
Social, economic, and health utility considerations in the treatment of overactive bladder. Open Access J Urol (2010) 1.00
A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder. BMC Med Res Methodol (2009) 0.84
Tolterodine and imipramine in refractory enuresis; a placebo-controlled crossover study. Pediatr Nephrol (2007) 0.82
Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial. World J Urol (2004) 0.81
Tolterodine extended release in the treatment of male OAB/storage LUTS: a systematic review. BMC Urol (2014) 0.80
Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women. BJU Int (2009) 0.80
Selecting a medical therapy for overactive bladder. Rev Urol (2002) 0.78
The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly. Clin Interv Aging (2009) 0.78
Persistence and compliance with medication management in the treatment of overactive bladder. Investig Clin Urol (2016) 0.77
A retrospective comparison of ring pessary and multicomponent behavioral therapy in managing overactive bladder. Int Urogynecol J (2014) 0.76
Cost-Effectiveness of Including a Nurse Specialist in the Treatment of Urinary Incontinence in Primary Care in the Netherlands. PLoS One (2015) 0.76
World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment. Clin Oral Investig (2015) 0.76
Combined Tolterodine and Vaginal Estradiol Cream for Overactive Bladder Symptoms After Randomized Single-Therapy Treatment. Female Pelvic Med Reconstr Surg (2016) 0.75
Oxybutynin: an overview of the available formulations. Ther Clin Risk Manag (2006) 0.75
Overactive bladder - 18 years - Part II. Int Braz J Urol (2016) 0.75
Botulinum toxin injections for treating neurogenic detrusor overactivity. Turk J Urol (2015) 0.75
Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies. Neurourol Urodyn (1997) 2.20
Definition and classification of urinary incontinence: recommendations of the Urodynamic Society. Neurourol Urodyn (1997) 1.52
A comparison of the effects on saliva output of oxybutynin chloride and tolterodine tartrate. Clin Ther (2001) 1.45
In situ anterior vaginal wall sling formation with preservation of the endopelvic fascia for treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (1998) 1.40
Urinary incontinence. Not a 'normal' part of aging. Postgrad Med (1991) 1.40
A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology (2001) 1.28
The histology and prognosis of prostatic cancer. J Urol (1967) 1.20
A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer. Urology (2001) 1.18
The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate. Cancer Invest (2002) 1.13
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Duplicated inferior vena cava simulating retroperitoneal lymphadenopathy in a patient with embryonal cell carcinoma of the testicle. J Urol (1986) 1.06
Advancements in pharmacologic management of the overactive bladder. Urology (2000) 1.06
Removal of UroLume endoprosthesis: experience of the North American Study Group for detrusor-sphincter dyssynergia application. J Urol (2000) 1.06
Injectable agents in the treatment of stress urinary incontinence in women: where are we now? Urology (2000) 1.05
Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76 TeV. Phys Rev Lett (2011) 1.05
A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. J Antimicrob Chemother (1999) 1.05
Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: a multicenter, placebo-controlled trial. Am J Obstet Gynecol (1995) 1.04
Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence. Urology (2007) 1.03
Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia. J Urol (1999) 0.98
Renal cell carcinoma and idiopathic thrombocytopenic purpura. Urology (1984) 0.98
Production of muons from heavy flavor decays at forward rapidity in pp and Pb-Pb collisions at sqrt[s(NN)]=2.76 TeV. Phys Rev Lett (2012) 0.98
The efficacy of urethrolysis without re-suspension for iatrogenic urethral obstruction. J Urol (1999) 0.98
Standards of efficacy for evaluation of treatment outcomes in urinary incontinence: recommendations of the Urodynamic Society. Neurourol Urodyn (1997) 0.97
Paravertebral block for breast cancer surgery. Can J Anaesth (1996) 0.96
Collagen injection therapy for female intrinsic sphincteric deficiency. J Urol (1997) 0.94
Intraoperative autotransfusion in urologic oncology. Arch Surg (1986) 0.94
Centrality dependence of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2011) 0.93
Doxazosin for benign prostatic hyperplasia: long-term efficacy and safety in hypertensive and normotensive patients. The Multicenter Study Group. J Urol (1997) 0.93
Transforming growth factor-alpha induces neurogenesis and behavioral improvement in a chronic stroke model. Neuroscience (2009) 0.90
Incidence of concomitant procedures for pelvic organ prolapse and reconstruction in women who undergo surgery for stress urinary incontinence. Urology (2001) 0.89
Midrapidity antiproton-to-proton ratio in pp collisons at sqrt[s]=0.9 and 7 TeV measured by the ALICE experiment. Phys Rev Lett (2010) 0.87
The effects of epidural anesthesia on the urethral closure pressure profile in patients with prostatic enlargement. J Urol (1980) 0.85
Urodynamic findings in postprostatectomy incontinence. Neurourol Urodyn (1998) 0.84
Leiomyosarcoma of renal vein. Urology (1977) 0.84
The use of the Magnetip double-J ureteral stent in urological practice. J Urol (1989) 0.84
A dose-response study of the effect of flutamide on benign prostatic hyperplasia: results of a multicenter study. Urology (1996) 0.84
Dry-heat destruction of lipopolysaccharide: design and construction of dry-heat destruction apparatus. Appl Environ Microbiol (1978) 0.83
Voiding dysfunction in women with diabetes mellitus. Int Urogynecol J Pelvic Floor Dysfunct (1999) 0.83
Surgical management of pelvic organ prolapse and stress urinary incontinence. Clin Obstet Gynecol (1998) 0.83
Preoperative angioinfarction of localized renal cell carcinoma using absolute ethanol. J Urol (1985) 0.82
The supine stress test: a simple method to detect intrinsic urethral sphincter dysfunction. J Urol (1999) 0.82
Differential diagnosis of scrotal pain after break dancing. JAMA (1984) 0.81
Transurethral collagen injection for urinary incontinence. Urology (1994) 0.81
Hemorrhage from congenital renal arteriovenous malformation in pregnancy. Urology (1984) 0.81
Tolterodine: a new antimuscarinic agent for the treatment of the overactive bladder. Expert Opin Investig Drugs (1999) 0.80
Medical writing. N Engl J Med (1979) 0.80
J/ψ polarization in pp collisions at √s=7 TeV. Phys Rev Lett (2012) 0.80
Oedema and fibrosis of the lungs in left ventricular failure. Br J Radiol (1968) 0.80
The in situ anterior vaginal wall sling: predictors of success. J Urol (2001) 0.80
A multicenter, double-blind, trimethoprim-sulfamethoxazole controlled study of enoxacin in the treatment of patients with complicated urinary tract infections. J Urol (1989) 0.79
Collagen injection therapy for post-prostatectomy incontinence. J Urol (1998) 0.79
Update on extracorporeal magnetic innervation (EXMI) therapy for stress urinary incontinence. Urology (2000) 0.79
Extracorporeal magnetic innervation therapy for stress urinary incontinence. Urology (1999) 0.79
Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer. J Urol (2008) 0.78
Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunction. Int J Impot Res (2002) 0.78
Ureterovaginal fistula detected by vaginogram. JAMA (1981) 0.78
Delivery of injectable agents for treatment of stress urinary incontinence in women: evolving techniques. Tech Urol (2001) 0.77
Bone anchor infections in female pelvic reconstructive procedures: a literature review of series and case reports. J Urol (2001) 0.77
A practical tracheal tube tie. Can J Anaesth (1998) 0.77
Occult bacterial colonization of bladder tumors. J Urol (1980) 0.76
Tolerability of solifenacin and oxybutynin immediate release in older (> 65 years) and younger (≤ 65 years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind study. Curr Med Res Opin (2010) 0.76
Use of bone anchors in female urology. Urology (2000) 0.76
The effect of temperature on the motility and viability of sperm. Br J Urol (1977) 0.76
A new continuous catheter delivery system. Anesth Analg (1998) 0.76
In situ slings with concurrent cystocele repair. Tech Urol (1999) 0.76
The effect of temperature on sperm motility and viability. Fertil Steril (1977) 0.76
Multicenter trial in North America of UroLume urinary sphincter prosthesis. J Urol (1994) 0.76
Primary slings for everyone with genuine stress incontinence? The argument for... Int Urogynecol J Pelvic Floor Dysfunct (1998) 0.76
Recent clinical studies of new pharmacologic agents and their efficacy in the treatment of incontinence. Rev Urol (2001) 0.76
Surgical treatment for stress urinary incontinence associated with valsalva induced detrusor instability. J Urol (2000) 0.76
Urinary incontinence. J Urol (1994) 0.75
Charged-particle multiplicity density at midrapidity in central Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 0.75
J/ψ suppression at forward rapidity in Pb-Pb collisions at √s(NN) = 2.76 TeV. Phys Rev Lett (2012) 0.75
Bladder instability in patients with prostatic hypertrophy. Postgrad Med J (1981) 0.75
Teloscopy. J Am Assoc Gynecol Laparosc (1998) 0.75
"When you build it, keep it simple": comment on "If you build it, they will come" (1998): Neurourol Urodynam 17:1-2. Neurourol Urodyn (1998) 0.75
Medical aspects of the Confederacy (1861--1865). South Med J (1980) 0.75
Thioridazine-induced priapism. Br J Urol (1977) 0.75
Retroperitoneal fibrosis and avascular necorsis of the femoral head. JAMA (1976) 0.75
The effect of temperature on sperm motility. II. Is bacterial growth a factor? Fertil Steril (1978) 0.75
Measurement of the cross section for electromagnetic dissociation with neutron emission in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 0.75
Paying attention to restrictive covenants. Pa Med (1997) 0.75
Reversible renal failure following intravascular contrast radiography. JAMA (1977) 0.75
The effects of hypophysectomy and human chorionic gonadotropin administration on the in vitro metabolism of progesterone by the rat testis. Steroids (1973) 0.75
Gas cystometry. Urol Clin North Am (1979) 0.75
Footprinting for identification of infants. Pediatrics (1969) 0.75
Percutaneous nephrostomy as an aid in the management of obstructing calculi in the severely ill patient. J La State Med Soc (1981) 0.75
Urodynamics I: the functional significance of bladder and urethral innervation. J La State Med Soc (1980) 0.75
Vasectomy: etiology of infectious complications. Fertil Steril (1980) 0.75
The external urethral barrier for stress incontinence: a multicenter trial of safety and efficacy. Miniguard Investigators Group. Obstet Gynecol (1999) 0.75
Calyceal injury due to external ureteric compression during urography. Br J Urol (1978) 0.75
Footprinting for identification of infants. Pediatrics (1968) 0.75
Office urodynamics. Urol Clin North Am (1979) 0.75
Idiopathic retroperitoneal fibrosis. J Urol (1980) 0.75
The value of a disease index in a nursing facility. Med Rec News (1976) 0.75